Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Akoya Biosciences Inc (NQ: AKYA ) 2.360 -0.050 (-2.07%) Streaming Delayed Price Updated: 11:31 AM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Akoya Biosciences Inc < Previous 1 2 Next > Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences July 15, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences Reports First Quarter 2024 Financial Results May 13, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients May 09, 2024 Leveraging Akoya’s market-leading PhenoImager HT platform and clinical development expertise with NeraCare’s Immunoprint test and best-in-class clinical data, the partnership will focus on increasing... From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts May 06, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows May 02, 2024 KR-HT5 is based on Akoya’s PhenoImager® HT Platform From Akoya Biosciences, Inc. Via GlobeNewswire Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024 April 22, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale April 05, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook March 04, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference February 08, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases January 18, 2024 PhenoCycler®-Fusion system selected as the Centre’s platform technology for advanced spatial biology studies From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board January 10, 2024 Leading immunotherapy and immunobiology experts will offer strategic direction and expertise in translational, clinical, and diagnostic applications of Akoya’s spatial biology solutions From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow January 07, 2024 The Thermo Fisher Scientific ViewRNA technology combined with Akoya’s market leading spatial biology solutions will enable rapid, whole-slide imaging of RNA and protein biomarkers From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform January 07, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook January 07, 2024 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya to Participate at 42nd Annual J.P. Morgan Healthcare Conference December 20, 2023 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Reports Record Revenue in the Third Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance November 08, 2023 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya to Participate at Three Upcoming Investor Conferences November 02, 2023 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences to Showcase New Spatial Biology 2.0 Solutions and Spatial Phenotyping Data at SITC 2023 October 31, 2023 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences Announces Peer-Reviewed Publication Using Ultrahigh-Plex Spatial Phenotyping of Head and Neck Cancer to Identify Distinct Immune and Metabolic Signatures October 17, 2023 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya to Report Third Quarter 2023 Financial Results on November 8th, 2023 October 11, 2023 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences Sets a New Standard for Scaling Spatial Biology with the Launch of 2.0 Platforms September 19, 2023 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Reports Record Revenue in the Second Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance August 07, 2023 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences Announces Milestone of 1,000 Peer-Reviewed Publications Citing Use of its Spatial Biology Technologies August 07, 2023 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya to Participate at Three Upcoming Investor Conferences July 26, 2023 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya to Report Second Quarter 2023 Financial Results on August 7th, 2023 July 12, 2023 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya to Participate at Two Upcoming Investor Conferences June 12, 2023 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences Announces Pricing of Public Offering of Common Stock June 08, 2023 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences Announces Public Offering of Common Stock June 07, 2023 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Reports Record Revenue in the First Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance May 08, 2023 From Akoya Biosciences, Inc. Via GlobeNewswire Akoya Biosciences Marks Milestone Achievement with Shipment of 1,000th Spatial Biology Instrument April 27, 2023 From Akoya Biosciences, Inc. Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.